References
Adamama-Moraitou KK, Patsikas MN, Koutinas AF. Feline lower airway disease: a retrospective study of 22 naturally occurring cases from Greece. Journal of Feline Medicine and Surgery.
2004; 6: 227-233.Allerton FJW, Leemans J, Tual C, Bernaerts F, Kirschvink N, Clercx C. Correlation of bronchoalveolar eosinophilic percentage with airway responsiveness in cats with chronic bronchial disease. Journal of Small Animal Practice. 2013; 54: 258-264.
Bellamy F, Bader T, Moussy A, Hermine O. Pharmacokinetics of masitinib in cats. Veterinary Research Communications. 2009; 33: 831-837.
Cocayne CG, Reinero CR, Declue AE. Subclinical airway inflammation despite high-dose oral corticosteroid therapy in cats with lower airway disease. Journal of Feline Medicine and Surgery. 2011; 13: 558-563.
Conboy G. Helminth parasites of the canine and feline respiratory tract. Veterinary Clinics of North America: Small Animal Practice. 2009; 39: 1109-1126.
Dye JA, Mckiernan BC, Rozanski EA, et al. Bronchopulmonary disease in the cat: historical, physical, radiographic, clinicopathologic, and pulmonary functional evaluation of 24 affected and 15 healthy cats. Journal of Veterinary Internal Medicine. 1996; 10: 385-400.
Foster SF, Martin P. Lower respiratory tract infections in cats: reaching beyond empirical and inactive. Individuals with treatment failure will be poorly responsive to treatment (glucocorticoids and bronchodilators) and respiratory difficulty/hypoxia will persist despite appropriate medications, increasing dosages, rescue therapies, and treatment duration. Severely affected cats (or those that cannot be treated) in treatment failure, where even mild activity induces respiratory distress, should be considered for euthanasia.
therapy. Journal of Feline Medicine and Surgery. 2011; 13: 313-332.
Grobman M, Graham A, Outi H, Dodam JR, Reinero CR.
Chronic neurokinin-1 receptor antagonism fails to ameliorate clinical signs, airway hyper-responsiveness or airway eosinophilia in an experimental model of feline asthma. Journal of Feline Medicine and Surgery. 2015a; 18(4): 273-279.Grobman M, Krumme S, Outi H, Dodam JR, Reinero C R. Acute neurokinin-1 receptor antagonism fails to dampen airflow limitation or airway eosinophilia in an experimental model of feline asthma. Journal of Feline Medicine and Surgery. (2015b) 18(2) 176-181.
Hawkins EC, Papich MG. Respiratory drug therapy. In: J Bonagura and D Twedt, Eds. Kirk's Current Veterinary Therapy XV. Saunders Elsevier. 2014: 622-628.
Johnson LR, Drazenovich TL. Flexible bronchoscopy and bronchoalveolar lavage in 68 cats (2001-2006). Journal of Veterinary Internal Medicine. 2007; 21: 219-225.
Johnson LR, Vernau W. Bronchoscopic findings in 48 cats with spontaneous lower respiratory tract disease (2002-2009). Journal of Veterinary Internal Medicine. 2011; 25: 236-243.
Lee-Fowler TM, Guntur V, Dodam J, Cohn LA, Declue AE, Reinero CR. The tyrosine kinase inhibitor masitinib blunts airway inflammation and improves associated lung mechanics in a feline model of chronic allergic asthma. International Archives of Allergy and Immunology. 2012; 158: 369-374.
Lin CH, Wu HD, Lee JJ, Liu CH. Functional phenotype and its correlation with therapeutic response and inflammatory type of bronchoalveolar lavage fluid in feline lower airway disease. Journal of Veterinary Internal Medicine. 2015; 29: 88-96.
Moise NS, Wiedenkeller D, Yeager AE, Blue JT, Scarlett J. Clinical, radiographic, and bronchial cytologic features of cats with bronchial disease: 65 cases (1980-1986). Journal of the American Veterinary Medical Association. 1989; 194: 1467-1473.
Nafe LA, Leach SB. Treatment of feline asthma with ciclosporin in a cat with diabetes mellitus and congestive heart failure. Journal of Feline Medicine and Surgery. 2014; 17(12): 1073-1076.
Nafe LA, Declue AE, Lee-Fowler TM, Eberhardt JM, Reinero CR.
Evaluation of biomarkers in bronchoalveolar lavage fluid for discrimination between asthma and chronic bronchitis in cats. American Journal of Veterinary Research. 2010; 71: 583-591.Nafe LA, Guntur VP, Dodam JR, Lee-Fowler TM, Cohn LA, Reinero CR. Nebulized lidocaine blunts airway hyperresponsiveness in experimental feline asthma. Journal of Feline Medicine and Surgery. 2013; 15: 712-716.
Padrid PA. Chronic bronchitis and asthma in cats. In: J Bonagura and D Twedt, Eds. Kirk's Current Veterinary Therapy XV. Saunders Elsevier. 2014: 673-680.
Reinero C. Management of feline inflammatory airway diseases. ACVIM Forum, 2015.
Reinero CR. Advances in the understanding of pathogenesis, and diagnostics and therapeutics for feline allergic asthma. The Veterinary Journal. 2011; 190: 28-33.
Reinero CR, Liu H, Chang CH. Flow cytometric determination of allergenspecific T lymphocyte proliferation from whole blood in experimentally asthmatic cats. Veterinary Immunology and Immunopathology. 2012; 149: 1-5.
Schooley EK, Turner JB, Jiji RD, Spinka CM, Reinero CR. Effects of cyproheptadine and cetirizine on eosinophilic airway inflammation in cats with experimentally induced asthma. American Journal of Veterinary Research. 2007; 68: 1265-1271.
Trzil JE, Reinero CR. Update on feline asthma. Veterinary Clinics of North America: Small Animal Practice. 2014; 44: 91-105.
Trzil JE, Masseau I, Webb TL, et al. Long-term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma. Clinical and Experimental Allergy. 2014; 44: 1546-1557.
Trzil JE, Masseau I, Webb TL, et al. Intravenous adipose-derived mesenchymal stem cell therapy for the treatment of feline asthma: a pilot study. Journal of Feline Medicine and Surgery 2015; 18(12): 981-990.
Ybarra WL, Johnson LR, DrazenovichTL, Johnson EG, Vernau W. Interpretation of multisegment bronchoalveolar lavage in cats (1/2001-1/2011). Journal of Veterinary Internal Medicine. 2012; 26: 1281-1287.